Debate—a bridge too far: Nonalcoholic fatty liver disease will not exhaust the donor pool
Jacqueline G. O'Leary – 27 August 2014
Sarcopenia and survival after liver transplantation
Katie Clark, T. J. S. Cross – 27 August 2014
Screening for Wilson's disease: Which tests are good enough?
Michelle Jesse, Robert Dempsey, Anne Eshelman, Dilip Moonka – 27 August 2014
Preparing for the inevitable: The death of a living liver donor
Charles Miller – 27 August 2014
Liver transplant patients have a risk of progression similar to that of sporadic patients with branch duct intraductal papillary mucinous neoplasms
Anne Marie Lennon, David Victor, Atif Zaheer, Mohammad Reza Ostovaneh, Jessica Jeh, Joanna K. Law, Neda Rezaee, Marco Dal Molin, Young Joon Ahn, Wenchuan Wu, Mouen A. Khashab, Mohit Girotra, Nita Ahuja, Martin A. Makary, Matthew J. Weiss, Kenzo Hirose, Michael Goggins, Ralph H. Hruban, Andrew Cameron, Christopher L. Wolfgang, Vikesh K. Singh, Ahmet Gurakar – 25 August 2014 – Intraductal papillary mucinous neoplasms (IPMNs) have malignant potential and can progress from low‐ to high‐grade dysplasia to invasive adenocarcinoma.
Portopulmonary hypertension: Diagnosis, clinical features, and medical therapy
Sonja D. Bartolome – 25 August 2014 – Watch a video presentation of this article
HPS: Diagnosis, clinical features, and medical therapy
Valentin Fuhrmann, Andreas Drolz, Karoline Rutter, Thomas Horvatits – 25 August 2014 – Watch a video presentation of this article
Portopulmonary hypertension: Diagnosis, clinical features, and medical therapy
Sonja D. Bartolome – 25 August 2014 – Watch a video presentation of this article
Hepatology Highlights
Jean‐François Dufour – 25 August 2014